Background
==========

Coal workers' pneumoconiosis (CWP), an irreversible fibrotic lung disorder, is associated with absorbing excessive coal dust particulates. CWP and silicosis are the predominant pneumoconioses, accounting for 95.5% of newly reported cases of occupational pneumoconiosis in 2016 in China. Notably, CWP accounted for nearly 60% of all new pneumoconiosis cases \[[@b1-medscimonit-26-e918709]\]. A systematic analysis in China reported a far higher prevalence of CWP in local government-owned mines compared with state-owned mines due to the different types of protection measures employed \[[@b2-medscimonit-26-e918709]\], highlighting again the vital importance of various coal dust exposures to CWP.

Free crystalline silica-containing coal dust accumulates in the lung, triggering inflammation, lung fibrosis, and chronic obstructive pulmonary disease. Such exposure activates resident macrophages to release pro-inflammatory cytokines, resulting in the promotion of dense collagen fiber formation in the lung and eventually the development of pulmonary fibrosis and focal emphysema. Additionally, a comparison of antioxidant enzymes between patients and controls \[[@b3-medscimonit-26-e918709],[@b4-medscimonit-26-e918709]\] revealed a possible role of oxidant injury in lung damage based on some oxidant markers.

As for many other occupational diseases, few of the people exposed to inorganic dust particulates develop CWP. Therefore, in addition to exposure factors, a genetic susceptibility has also been illustrated in the pathogenesis of CWP. Previous studies suggested relationships of single-nucleotide polymorphisms (SNPs) in *MUC5B*, *NLRP3*, and *TICAM1* genes with pneumoconiosis, providing new insights into CWP pathogenesis \[[@b5-medscimonit-26-e918709]--[@b7-medscimonit-26-e918709]\]. Because CWP is characterized by lung fibrosis, we wondered whether pulmonary fibrosis is correlated with genetic variations in the context of CWP predisposition. Previously, studies showed that another fibrotic lung disorder, idiopathic pulmonary fibrosis (IPF), is associated with telomerase RNA component (*TERC*) and telomerase reverse transcriptase (*TERT*) genes \[[@b8-medscimonit-26-e918709]\]. These 2 genes are telomere-related genes with the function of regulating telomere length. Additionally, gene nuclear assembly factor 1 (*NAF1*) can affect telomere activity through the association of NAF1 protein with other proteins such as TERT to form the telomerase enzyme. These findings indicate that pulmonary fibrosis-emphysema patients have frameshift mutations in *NAF1* \[[@b9-medscimonit-26-e918709]\]. Based on the association between lung fibrosis and telomere-related genes, the present study aimed to investigate the correlation between mutations in *TERC*, *TERT*, and *NAF1* and CWP susceptibility in a Chinese Han population.

Material and Methods
====================

Study population
----------------

We enrolled 652 male Han Chinese patients with CWP in the study from February 2011 to December 2015. CWP was diagnosed for pneumoconiosis according to the China National Diagnostic Criteria (GBZ70-2009). A total of 648 unrelated male dust-exposed controls were recruited from the Kailuan mining area from March to June 2015. The controls were subjected to X-ray and physical examinations to exclude CWP. The case subjects were divided into 2 groups exposed to either coal dust or rock dust. The coal dust group included 303 cases and 321 controls, whereas the rock dust group included 349 cases and 327 controls. Both groups consisted of heading drivers, coal diggers, and workers who performed both jobs. The present study was approved by the Ethics Committee of Kailuan General Hospital.

SNPs selection
--------------

As shown in [Table 1](#t1-medscimonit-26-e918709){ref-type="table"}, we genotyped 8 SNPs. Among them, rs10936599 from *TERC* and rs2736100 from *TERT* are associated with pulmonary fibrosis \[[@b8-medscimonit-26-e918709]\], whereas rs12696304 is near *TERC* and rs7675998 of *NAF1* is related to mean telomere length. Additionally, 4 variants (rs3822304, rs12331717, rs936562, and rs4691896) on the untranslated region (UTR) and exon region of *NAF1* were also analyzed ([Table 1](#t1-medscimonit-26-e918709){ref-type="table"}).

DNA extraction and genotyping
-----------------------------

Genomic DNA from each participant was extracted from peripheral blood using genomic DNA kits (Tiangen, Beijing, China). The genotyping of the SNPs of 3 candidate genes was conducted using the Agena MassARRAY system (San Diego, CA, USA) through matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS). The subsequent products were dispensed onto a 384-element Spectro CHIP array for analysis with MassARRAY Typer v4.0.

Statistical analysis
--------------------

Eight SNPs were genotyped in controls, and the Hardy-Weinberg equilibrium (HWE) of SNPs was analyzed using the χ^2^ test. We performed association analyses using PLINK 1.07 software (Shaun Purcell, Boston, MA). Associations were analyzed by comparing the frequencies of each allele in cases and controls, and odds ratios (ORs) were calculated. *Pc*\<0.05 after Bonferroni correction was considered indicative of a statistically significant difference. Additionally, genetic models for the variants were assessed. Linkage disequilibrium (LD) analysis was conducted using Haploview v4.2.

Results
=======

Population characteristics
--------------------------

The study included 652 patients with CWP (mean age±standard deviation \[SD\]: 62.7±5.9) and 648 controls (mean age±SD: 60.9±7.3). The average durations of exposure to dust in the patients and controls were 25.8±4.4 years and 23.6±4.1 years, respectively. The smoking rates in cases and controls were 55.2% (360/652) and 51.5% (334/648), respectively. The basic characteristics of age, smoking rate, and exposure duration were all comparable between the patient and control groups (*P*\>0.05).

SNP allele and genotype analysis between cases and controls
-----------------------------------------------------------

The genotype frequencies of 8 SNPs in 3 genes in the control group were all distributed according to HWE criteria (*Pc*\>0.05, [Table 1](#t1-medscimonit-26-e918709){ref-type="table"}). The genotyping of the quality control sample was completely consistent, and the call rate for each SNP was greater than 97%.

As shown in [Table 2](#t2-medscimonit-26-e918709){ref-type="table"}, the minor allele T frequencies of rs4691896 in *NAF1* in CWP cases and in controls were 22.0% and 13.0%, respectively. The G allele frequencies of genetic variant rs3822304 of *NAF1* in CWP cases and in controls were 3.3% and 1.7%, respectively. The results showed that both rs4691896-T (OR: 1.89, 95% CI: 1.54--2.33, *Pc*=1.14×10^−8^) and rs3822304-G (OR: 1.96, 95% CI: 1.17--3.30, *P*=0.01) were more common in patients than in healthy subjects. The C allele of rs2736100 from *TERT* showed a lower allele frequency in the patients with CWP than in the healthy subjects (38.4% *vs*. 42.7%, OR: 0.84, 95% CI: 0.72--0.98, *P*=0.04). There was no significant association of rs3822304 and rs2736100 with CWP after Bonferroni correction.

As shown in [Table 3](#t3-medscimonit-26-e918709){ref-type="table"}, the genotype frequency of rs4691896 in *NAF1* differed significantly between the cases and controls (*Pc*=1.49×10^−8^). Seven SNPs (rs10936599 and rs12696304 from *TERC*, rs2736100 of *TERT* and rs7675998, rs3822304, rs12331717, and rs936562 from *NAF1*) were found to be negatively associated with CWP.

Genetic model analysis of candidate genes
-----------------------------------------

As shown in [Table 4](#t4-medscimonit-26-e918709){ref-type="table"}, among the 8 SNPs, only rs4691896 of *NAF1* was significantly correlated with CWP in the additive genetic model (OR: 1.96, 95% CI: 1.58--2.44, *Pc=*8.96×10^−9^) and dominant model (OR: 2.15, 95% CI: 1.70--2.73, *Pc=*2.39×10^−9^), whereas the other 7 SNPs showed no significant association with CWP in any genetic model (*Pc*\>0.05).

LD analysis of *NAF1*
---------------------

The outcomes of LD analysis are shown in [Figures 1](#f1-medscimonit-26-e918709){ref-type="fig"} and [2](#f2-medscimonit-26-e918709){ref-type="fig"}, and the data show that rs7675998, rs4691896, and rs936562 of NAF1 were in strong LD (D' \>0.7, r^2^ \>0.3).

Discussion
==========

Our study showed that *NAF1*, a telomere length maintenance gene, was associated with CWP, which suggests that CWP has susceptibility genes in common with pulmonary fibrosis, providing a clue to the pathogenesis of CWP.

Telomeres located at linear chromosome ends are protective structures, playing a role in preventing genome instability. Telomere shortening accelerates the process of aging during cell division. Mutations in genes needed for telomere maintenance generate a spectrum of diseases such as telomeropathies, including pulmonary fibrosis and liver fibrosis, in addition to aplastic anemia \[[@b8-medscimonit-26-e918709],[@b10-medscimonit-26-e918709]\]. Many studies have shown that telomere dysfunction is involved in the etiologies of IPF, familial pulmonary fibrosis, and pulmonary fibrosis-emphysema \[[@b11-medscimonit-26-e918709]--[@b14-medscimonit-26-e918709]\]. Moreover, IPF patients with shorter telomeres have shorter survival times than those with longer telomeres \[[@b14-medscimonit-26-e918709],[@b15-medscimonit-26-e918709]\]. Telomere length less than the 10th percentile was shown to be associated with poor prognosis in IPF patients \[[@b16-medscimonit-26-e918709]\]. Interestingly, telomere length was proven to be related to fibrotic joint conditions, such as hip stiffness, knee stiffness, and frozen shoulder \[[@b17-medscimonit-26-e918709]\]. The evidence described suggests that telomere deficiency is a shared mechanistic pathway for fibrotic disorders.

*NAF1* is an essential protein required for the biogenesis of H/ACA box small nucleolar RNAs, which are abundant non-coding RNAs, and thus has important functions in telomeric DNA synthesis \[[@b18-medscimonit-26-e918709]\]. Frameshift mutations in pulmonary fibrosis-emphysema patients result in short telomere length and low telomerase RNA levels. SNP rs4691896 in the second exon of *NAF1* is a missense variant (c.484A\>G) that causes replacement of isoleucine (Ile) with valine (Val) (Ile162Val). The rs4691896-coded amino acid is located outside of the globular domain Naf1 RNA-binding region, without effect on the proper function of *NAF1* by PolyPhen \[[@b19-medscimonit-26-e918709]\]. Prediction using the web-based software MUpro v1.0 confirmed that the Val162 variant can decrease the stability of the protein structure of *NAF1* \[[@b20-medscimonit-26-e918709]\]. Thus, the evidence suggests that SNP rs4691896 is related to pulmonary fibrosis in pneumoconiosis via an effect on *NAF1* stability, but this must be validated further.

Our study has several limitations. Although the duration of dust exposure and the smoking rate were matched in CWP patients and healthy controls, we did not consider their levels. We also need to validate the genetic variant in independent CWP cohorts to ensure the positive association.

Conclusions
===========

In conclusion, this case-control study demonstrates for the first time that a genetic variation of *NAF1* can increase susceptibility to CWP and provides valuable information for better understanding the pathogenesis of this disease. Further studies are required to validate the relationship of telomerase level and telomere length with pulmonary fibrosis in CWP.
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###### 

HWE test of 8 SNPs.

  Gene     SNP          Minor allele/major allele   Position          Function                                     *P*      *Pc* for HWE
  -------- ------------ --------------------------- ----------------- -------------------------------------------- -------- --------------
  *TERC*   rs10936599   C/T                         Chr3: 169774313   9.3 kB upstream of TERC                      0.52     NS
  *TERC*   rs12696304   C/G                         Chr3: 169763483   1.5 kB downstream of TERC                    0.85     NS
  *TERT*   rs2736100    C/A                         Chr5: 1286401     Intron variant                               0.93     NS
  *NAF1*   rs7675998    A/G                         Chr4: 163086668   80 kB downstream of TERC                     0.89     NS
  *NAF1*   rs3822304    G/C                         Chr4: 163166899   Upstream variant 2 kB, UTR variant 5 prime   \>0.99   NS
  *NAF1*   rs12331717   T/C                         Chr4: 163166907   Upstream variant 2 kB, UTR variant 5 prime   0.19     NS
  *NAF1*   rs936562     A/T                         Chr4: 163166802   UTR variant 5 prime                          0.72     NS
  *NAF1*   rs4691896    T/C                         Chr4: 163164273   Missense variant, exon variant               \>0.99   NS

HWE -- Hardy-Weinberg equilibrium; SNPs -- single-nucleotide polymorphisms; *Pc* -- p value corrected by Bonferroni method; NS -- not significant.

###### 

Allele distribution of case-control association analysis.

  Gene     SNP          Minor allele/ major allele   CWP group, n (%)   Exposed control group, n (%)   OR (95%CI)    *P*            *Pc*                              
  -------- ------------ ---------------------------- ------------------ ------------------------------ ------------- -------------- ------------------- ------------- -------------
  *TERC*   rs10936599   C/T                          579 (44.7%)        715 (55.3%)                    576 (45.1%)   702 (54.9%)    0.99 (0.85--1.15)   0.89          NS
  *TERC*   rs12696304   C/G                          412 (31.7%)        886 (68.3%)                    395 (30.8%)   887 (69.2%)    1.04 (0.88--1.23)   0.62          NS
  *TERT*   rs2736100    C/A                          496 (38.4%)        794 (61.6%)                    534 (42.7%)   718 (57.3%)    0.84 (0.72--0.98)   0.04          NS
  *NAF1*   rs7675998    A/G                          234 (18.0%)        1064 (82.05)                   213 (16.5%)   1077 (83.5%)   1.11 (0.91--1.36)   0.31          NS
  *NAF1*   rs3822304    G/C                          43 (3.3%)          1259 (96.7%)                   22 (1.7%)     1264 (98.2%)   1.96 (1.17--3.30)   0.01          NS
  *NAF1*   rs12331717   T/C                          64 (4.9%)          1234 (95.1%)                   63 (4.9%)     1233 (95.1%)   1.02 (0.71--1.45)   0.94          NS
  *NAF1*   rs936562     A/T                          287 (22.2%)        1007 (77.8%)                   273 (21.3%)   1007 (78.7%)   1.05 (0.87--1.27)   0.60          NS
  *NAF1*   rs4691896    T/C                          287 (22.0%)        1017 (78.0%)                   168 (13.0%)   1126 (87.0%)   1.89 (1.54--2.33)   1.43×10^−9^   1.14×10^−8^

SNP -- single-nucleotide polymorphism; CWP -- coal workers' pneumoconiosis; OR -- odds ratio; CI -- confidence interval; *Pc* -- p value corrected by Bonferroni method; NS -- not significant.

###### 

Genotype distribution of candidate genes in CWP cases and dust-exposed controls.

  Gene     SNP          Minor allele/ major allele   CWP group, n (%)   Exposed control group, n (%)   χ^2^          *P*           *Pc*                                              
  -------- ------------ ---------------------------- ------------------ ------------------------------ ------------- ------------- ------------- ------------- ------- ------------- -------------
  *TERC*   rs10936599   C/T                          137 (21.2%)        305 (47.1%)                    205 (31.7%)   134 (21.0%)   308 (48.2%)   197 (30.8%)   0.16    0.92          NS
  *TERC*   rs12696304   C/G                          74 (11.4%)         264 (40.7%)                    311 (47.9%)   62 (9.7%)     271 (42.3%)   308 (48.0%)   1.12    0.57          NS
  *TERT*   rs2736100    A/C                          105 (16.3%)        286 (44.3%)                    254 (39.4%)   113 (18.1%)   308 (49.2%)   205 (32.7%)   6.06    0.05          NS
  *NAF1*   rs7675998    A/G                          14 (2.2%)          206 (31.7%)                    429 (66.1%)   18 (2.8%)     177 (27.4%)   450 (69.8%)   3.19    0.20          NS
  *NAF1*   rs3822304    C/G                          1 (0.2%)           41 (6.2%)                      609 (93.5%)   0 (0%)        22 (3.4%)     621 (96.6%)   6.80    0.03          NS
  *NAF1*   rs12331717   C/T                          4 (0.6%)           56 (8.6%)                      589 (90.8%)   3 (0.5%)      57 (8.8%)     588 (90.7%)   0.15    0.93          NS
  *NAF1*   rs936562     A/T                          23 (3.6%)          241 (37.2%)                    383 (59.2%)   27 (4.2%)     219 (34.2%)   394 (61.6%)   1.49    0.48          NS
  *NAF1*   rs4691896    C/T                          21 (3.2%)          245 (37.6%)                    386 (59.2%)   11 (1.7%)     146 (22.65)   490 (75.7%)   40.52   1.86×10^−9^   1.49×10^−8^

CWP -- coal workers' pneumoconiosis; SNP -- single-nucleotide polymorphism; *Pc* -- p value corrected by Bonferroni method.

###### 

Analysis of candidate SNPs based on 3 genetic models with logistic regression analysis.

  Gene     SNP          Additive model      Dominant model   Recessive model                                                                               
  -------- ------------ ------------------- ---------------- ----------------- ------------------- -------------- ------------- ------------------- ------ ----
  *TERC*   rs10936599   0.99 (0.85--1.15)   0.87             NS                0.96 (0.76--1.22)   0.74           NS            1.01 (0.77--1.32)   0.93   NS
  *TERC*   rs12696304   1.04 (0.89--1.23)   0.62             NS                1.01 (0.81--1.25)   0.96           NS            1.20 (0.84--1.72)   0.31   NS
  *TERT*   rs2736100    0.84 (0.72--0.99)   0.03             NS                0.75 (0.60--0.94)   0.01           NS            0.88 (0.66--1.18)   0.40   NS
  *NAF1*   rs7675998    1.12 (0.91--1.37)   0.30             NS                1.18 (0.94--1.50)   0.16           NS            0.77 (0.38--1.56)   0.46   NS
  *NAF1*   rs3822304    1.96 (1.16--3.30)   0.01             NS                1.95 (1.15--3.30)   0.01           NS            NA                  1.00   NS
  *NAF1*   rs12331717   1.01 (0.72--1.43)   0.94             NS                1.00 (0.69--1.45)   0.99           NS            1.33 (0.30--5.98)   0.71   NS
  *NAF1*   rs936562     1.05 (0.87--1.28)   0.59             NS                1.10 (0.88--1.38)   0.39           NS            0.84 (0.48--1.48)   0.54   NS
  *NAF1*   rs4691896    1.96 (1.58--2.44)   1.12×10^−9^      8.96×10^−9^       2.15 (1.70--2.73)   2.99×10^−10^   2.39×10^−9^   1.92 (0.92--4.02)   0.82   NS

SNPs -- single-nucleotide polymorphisms; OR -- odds ratio; CI -- confidence interval; *Pc* -- p value corrected by Bonferroni method; NS -- not significant.
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